{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:28:31Z","timestamp":1788290911567,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.heliyon.2024.e30287","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T23:27:42Z","timestamp":1714087662000},"page":"e30287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Identification of potent inhibitors of kynurenine-3-monooxygenase from natural products: In silico and in vitro approaches"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2366-7639","authenticated-orcid":false,"given":"Redouane","family":"Rebai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2735-4859","authenticated-orcid":false,"given":"Miguel","family":"Carmena-Bargue\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4429-5399","authenticated-orcid":false,"given":"Mohammed Esseddik","family":"Toumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imene","family":"Derardja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4463-9001","authenticated-orcid":false,"given":"Luc","family":"Jasmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"P\u00e9rez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdennacer","family":"Boudah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2024.e30287_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00213-017-4780-9","article-title":"Prenatal kynurenine treatment in rats causes schizophrenia-like broad monitoring deficits in adulthood","volume":"235","author":"Hahn","year":"2018","journal-title":"Psychopharmacol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e30287_bib2","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1038\/s41380-019-0401-9","article-title":"Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia","volume":"25","author":"Kindler","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30287_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","article-title":"The kynurenine pathway: a finger in every pie","volume":"25","author":"Savitz","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e30287_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.drudis.2015.11.001","article-title":"G. J. Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors","volume":"21","author":"Smith","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30287_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s42003-019-0520-5","article-title":"A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites","volume":"2","author":"Zhang","year":"2019","journal-title":"Commun. Biol."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e30287_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000515066","article-title":"Combination and kynurenine pathway enzyme inhibitors in the treatment of neuropsychiatric disorders","volume":"7","author":"Bai","year":"2021","journal-title":"Complex Psychiatry"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30287_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms15827","article-title":"Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase","volume":"8","author":"Hutchinson","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e30287_bib8","first-page":"1","article-title":"Designing a natural inhibitor against human kynurenine aminotransferase type II and a comparison with PF-04859989: a computational effort against schizophrenia","author":"Noorbakhsh","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e30287_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hipo.23040","article-title":"Inhibition of kynurenine aminotransferase II attenuates hippocampus\u2010dependent memory deficit in adult rats treated prenatally with kynurenine","volume":"29","author":"Pocivavsek","year":"2019","journal-title":"Hippocampus"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30287_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.expneurol.2005.07.004","article-title":"Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: implications for Huntington's disease","volume":"197","author":"Sapko","year":"2006","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e30287_bib11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e30287_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240653","article-title":"Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: a molecular docking and simulation studies","volume":"15","author":"Cherrak","year":"2020","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.heliyon.2024.e30287_bib13","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.3390\/molecules26175377","article-title":"Plant flavonoids: chemical characteristics and biological activity","volume":"26","author":"Dias","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30287_bib14","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1080\/14756366.2019.1640218","article-title":"Inhibitory effects of flavonoids isolated from Sophora flavescens on indoleamine 2, 3-dioxygenase 1 activity","volume":"34","author":"Kwon","year":"2019","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30287_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.33945\/SAMI\/AJCB.2019.1.4","article-title":"Flavonoid derivatives for monoamine oxidase\u2013A inhibition","volume":"1","author":"Esfahani","year":"2019","journal-title":"Adv. J. Chem. B"},{"issue":"14","key":"10.1016\/j.heliyon.2024.e30287_bib16","first-page":"1","article-title":"High-throughput parallel blind virtual screening using BINDSURF","volume":"13","author":"S\u00e1nchez-Linares","year":"2012","journal-title":"BMC Bioinf."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30287_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e30287_bib19","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e30287_bib17","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1021\/acs.jcim.6b00174","article-title":"SwissSimilarity: a web tool for low to ultra high throughput ligand-based virtual screening","volume":"56","author":"Zoete","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.heliyon.2024.e30287_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30287_bib21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1063\/1.447334","article-title":"A unified formulation of the constant temperature molecular dynamics methods","volume":"81","author":"Nos\u00e9","year":"1984","journal-title":"J. Chem. Phys."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e30287_bib22","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/biology11101416","article-title":"Gram-scale preparation of cannflavin A from hemp (Cannabis sativa L.) and its inhibitory effect on tryptophan catabolism enzyme kynurenine-3-monooxygenase","volume":"11","author":"Puopolo","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.heliyon.2024.e30287_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113865","article-title":"Trichiliacatigua and Turneradiffusa extracts: in vitro inhibition of tyrosinase, antiglycation activity and effects on enzymes and pathways engaged in the neuroinflammatory process","volume":"271","author":"Bernardo","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e30287_bib24","first-page":"1","article-title":"Therapeutic benefits of flavonoids against neuroinflammation: a systematic review","author":"Hamsalakshmi","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e30287_bib25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/acschemneuro.1c00750","article-title":"Bidirectional responses of eight neuroinflammation-related transcriptional factors to 64 flavonoids in astrocytes with transposable insulated signaling pathway reporters","volume":"13","author":"Mossine","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"20","key":"10.1016\/j.heliyon.2024.e30287_bib26","doi-asserted-by":"crossref","first-page":"9974","DOI":"10.1080\/07391102.2021.1938233","article-title":"Synthesis, biological evaluation and molecular dynamics studies of oxadiazine derivatives as potential anti-hepatotoxic agents","volume":"40","author":"Akbar","year":"2022","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024063187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024063187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:16:18Z","timestamp":1775733378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024063187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2405844024063187"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30287","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of potent inhibitors of kynurenine-3-monooxygenase from natural products: In silico and in vitro approaches","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e30287"}}